Core Viewpoint - The stock of HeartTech Medical (02291) has dropped over 10%, currently trading at 24.5 HKD, with a transaction volume of 283 million HKD due to a significant share sale by a major shareholder, Lepu Medical [1] Group 1: Shareholder Activity - Lepu Medical announced the sale of a total of 11.14 million H-shares of HeartTech Medical at a price of 22.79 HKD per share, representing approximately 3.21% of the total issued shares as of the announcement date [1] - After the sale, Lepu Medical will continue to hold 268.86 million shares, which includes 266.06 million shares directly held and 2.8 million shares held by its subsidiary, accounting for about 77.54% of the total issued share capital as of the announcement date [1] Group 2: Company Confidence - The announcement emphasized Lepu Medical's strong confidence in the operational performance of HeartTech Medical, stating that the sale was aimed at enhancing the liquidity of the company's stock [1]